Level of Salivary Uric Acid in Gingivitis and Periodontitis Patients

Muhammad Ihsan Rizal, Stiefani Vega


Background: Periodontal disease is common chronic adult condition. Antioxidants are present in the body fluid as protection against free radical. Uric acid is one of antioxidants that can be found in saliva. Moreover, the relationship among the antioxidant enzymes activities and clinical periodontal status were investigated. Objectives: The aim of the study was to observe uric acid level activities in the saliva of gingivitis and periodontitis patients. Methods: Six patients with gingivitis and six patients with periodontitis in Dental Hospital Trisakti University were included in the study. Clinical condition of each subject, the plaque index, and probing depth were determined. The salivary uric acid level was measured using the Folin-Wu method. Result: Salivary uric acid levels in the periodontitis patients with a mean ± SD  7.40 ± 0.31  (p = 0.004) were found to be higher compared to the gingivitis patients (mean ± SD = 6.84 ± 0.19). In addition, there were no significant differences in salivary uric acid levels between gender (p = 0.641). Conclusion: Uric acid levels in periodontitis patients were found to be higher than in gingivitis patients. Moreover, uric acid has more role on periodontitis than in gingivitis as an antioxidant agent.


DOI : https://doi.org/10.26912/sdj.2017.01.01-02

Full Text:



Sculley DV, Langley-Evan SC. Salivary antioxidant and periodontal diseases status.UK: Proceeding of the Nutrition Society. 2002. 61: 137 - 143. DOI: 10.1079/PNS2001141

Newman MG. Etiology of periodontal diseases. In Caranza. editor. Carranza’s Clinical Periodontology. Philedelphia: WB Saunders. 2004. 910.

Canakci CF, Cicek Y, Yildirim A, Sezer Y, Canakci, V. Increased Levels of 8-Hydroxydeoxyguanosine and Malondialdehyde and its Relationship with Antioxidant Enzymes in Saliva of Periodontitis Patients. 2009; 3(2): 100-106.

Miyasaki KT, Nisengard RJ, Haake SK. Immunity and inflammation: Basic Conscepts. In Caranza. editor. Carranza’s Clinical Periodontology. 8th Edition. Co. Philadelphia: WB Saunders. 2002; 122-123.

Smith CM, Marks AD, Lieberman MA, Marks DB, Marks' Basic Medical Biochemistry: A Clinical Approach. Philadelphia: Lippincott Williams & Wilkins, 2005.

Cory JG. Purine and Pyrimidine Nucleotide Metabolism. In Textbook of Biochemistry With Clinical Correlation. 6th ed. USA: Wiley-Liss; 2006; 799 – 800.

Miricescu, D, Grebu, M, Totan, A, Didilescu, A, Radulescu, R.. The Antioxidant Potential Of Saliva: Clinical Significance in Oral Diseases. Therapeutics, Pharmacology and Clinical Toxicology. 2011; 15; 139-143.

Battino M, Bullon P, Wilson M, Newman H. Oxidative Injury and Inflammatory Periodontal Diseases: The Challenge of Anti – Oxidants To Free Radicals and Reactive Oxygen Species. CROBM: 1999; 10 : 458. DOI: 10.1177/10454411990100040301

Nagler RM, Reznick AZ. Cigarette Smoke Effects on Salivary Antioxidant and Oral Cancer – Novel Concepts. IMAJ. 2004. 6 : 691 – 694.

Kim, Sang – Chul, Kim Ok-Su, Kim Ok-Joon, Kim, Young-Joon, Chung, Hyun- Ju. Antioxidant Profile of Whole Saliva After Scaling and Root Planing in Periodontal Disease. J Periodontal Implant. 2010; 40: 164 – 171. DOI: 10.5051/jpis.2010.40.4.164

Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010. 4 (8) 118-126. DOI: 10.4103/0973-7847.70902

Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochimica et Biophysica Acta. 1997. 221–231. DOI: 10.1016/S0925-4439(97)00083-5

Waddington RJ, Moseley R, Embery G. Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis. 2000. 138-151. DOI: 10.1111/j.1601-0825.2000.tb00325.x


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.